Towa Pharmaceutical Co., Ltd.
TWAPF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $26,330 | $16,173 | $4,605 | $22,246 |
| Dep. & Amort. | $20,099 | $17,888 | $19,409 | $10,954 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$3,896 | -$32,574 | -$13,747 | -$3,102 |
| Other Non-Cash | -$19,132 | $6,725 | -$7,723 | -$7,969 |
| Operating Cash Flow | $23,401 | $8,212 | $2,544 | $22,129 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$28,736 | -$37,851 | -$30,469 | -$13,576 |
| Net Acquisitions | $0 | -$1,570 | -$1,484 | -$45,405 |
| Inv. Purchases | -$203 | -$50 | -$301 | -$1 |
| Inv. Sales/Matur. | $0 | $0 | $34 | $18 |
| Other Inv. Act. | -$2,348 | -$923 | $1,936 | -$765 |
| Investing Cash Flow | -$31,287 | -$40,394 | -$30,284 | -$59,729 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $15,376 | $38,560 | $20,883 | $49,114 |
| Stock Issued | $0 | $0 | $0 | $21 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$2,953 | -$2,952 | -$3,100 | -$2,411 |
| Other Fin. Act. | $9,144 | -$201 | -$302 | -$184 |
| Financing Cash Flow | $21,567 | $35,407 | $17,481 | $46,540 |
| Forex Effect | $1,916 | $2,167 | $1,685 | $975 |
| Net Chg. in Cash | $15,810 | $5,393 | -$8,573 | $9,915 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29,650 | $24,257 | $32,830 | $22,915 |
| End Cash | $45,460 | $29,650 | $24,257 | $32,830 |
| Free Cash Flow | -$7,822 | -$31,113 | -$27,925 | $8,553 |